Avant-garde Health Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$12M
- Investors
-
10
Avant-garde Health General Information
Description
Developer of a data analytics platform intended to help in clinical decision-making. The company's platform measures the costs of care processes, compares treatment-specific data, and learns from peer hospitals to improve their results, thus providing healthcare providers with actionable insights to understand and improve their costs and outcomes.
Contact Information
Website
www.avantgardehealth.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Primary Office
- Harvard Launch Lab
- 114 Western Avenue, Allston
- Boston, MA 02134
- United States
+1 (617) 000-0000
Avant-garde Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 10-Mar-2022 | $12M | 000.00 | 0000 | Completed | Generating Revenue |
| 3. Seed Round | 31-May-2017 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 2. Accelerator/Incubator | 01-Jan-2017 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Avant-garde Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A | 0,000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Seed 1 | 134,393 | $0.000100 | $2.23 | $2.23 | 1x | $2.23 | 2.5% | |
| Seed | 1,069,772 | $0.000100 | $3.72 | $3.72 | 1x | $3.72 | 19.88% |
Avant-garde Health Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Derek Haas | Founder, Chief Executive Officer, President & Board Member | ||
| Aditya Govil | Director, Business Development |
Avant-garde Health Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Frankel | Founder Collective | Board Member | 000 0000 |
| Derek Haas | Avant-garde Health | Founder, Chief Executive Officer, President & Board Member | 000 0000 |
| Matthew Rhodes-Kropf Ph.D | Tectonic Ventures | Board Member | 000 0000 |
| Philip Lewis | Fulcrum Equity Partners | Board Member | 000 0000 |
Avant-garde Health Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Avant-garde Health Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Fulcrum Equity Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Sparta Group | Limited Partner | Minority | 000 0000 | 000000 0 | |
| Founder Collective | Venture Capital | Minority | 000 0000 | 000000 0 | |
| General Catalyst | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Rothman Orthopaedic | Corporation | Minority | 000 0000 | 000000 0 |